ES465514A1 - Glucosamine derivatives and a process for their manufacture - Google Patents

Glucosamine derivatives and a process for their manufacture

Info

Publication number
ES465514A1
ES465514A1 ES465514A ES465514A ES465514A1 ES 465514 A1 ES465514 A1 ES 465514A1 ES 465514 A ES465514 A ES 465514A ES 465514 A ES465514 A ES 465514A ES 465514 A1 ES465514 A1 ES 465514A1
Authority
ES
Spain
Prior art keywords
glucosamine derivatives
manufacture
increase
glucosamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES465514A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES465514A1 publication Critical patent/ES465514A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Glucosamine derivatives of the formula < IMAGE > (X, R, R1, R2, R4, R6-R9 have the meaning stated in Claim 1) are prepared by condensation of corresponding 3-O-carboxymethylglucopyranosides with corresponding dipeptides. These glucosamine derivatives have the ability to increase the immunogenicity of an antigen on admixture therewith and, on systemic administration, to enhance the immunological reactivity of the treated organism. They can thus be used as adjuvants to increase the vaccine protection from bacterial, viral or parasitic pathogens.
ES465514A 1975-12-10 1977-12-28 Glucosamine derivatives and a process for their manufacture Expired ES465514A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
ES465514A1 true ES465514A1 (en) 1978-09-16

Family

ID=4414012

Family Applications (2)

Application Number Title Priority Date Filing Date
ES454118A Expired ES454118A1 (en) 1975-12-10 1976-12-10 Glucosamine derivatives and a process for their manufacture
ES465514A Expired ES465514A1 (en) 1975-12-10 1977-12-28 Glucosamine derivatives and a process for their manufacture

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES454118A Expired ES454118A1 (en) 1975-12-10 1976-12-10 Glucosamine derivatives and a process for their manufacture

Country Status (30)

Country Link
JP (1) JPS5273820A (en)
AR (2) AR224091A1 (en)
AT (1) AT365607B (en)
AU (1) AU508764B2 (en)
BE (1) BE849214A (en)
CA (1) CA1262400A (en)
CH (2) CH613709A5 (en)
CS (4) CS205026B2 (en)
DD (1) DD129781A5 (en)
DE (1) DE2655500A1 (en)
DK (1) DK154654C (en)
ES (2) ES454118A1 (en)
FI (1) FI64164C (en)
FR (1) FR2361902A1 (en)
GB (1) GB1570625A (en)
GR (1) GR61647B (en)
HK (1) HK32883A (en)
HU (1) HU177970B (en)
IE (1) IE44190B1 (en)
IL (1) IL51076A (en)
MY (1) MY8400123A (en)
NL (1) NL7613666A (en)
NO (1) NO144850C (en)
NZ (1) NZ182837A (en)
PL (4) PL110787B1 (en)
PT (1) PT65946B (en)
SE (1) SE445923B (en)
SG (1) SG11083G (en)
SU (3) SU660589A3 (en)
ZA (1) ZA767333B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (en) * 1978-03-20 1980-06-20 Anvar NOVEL ESTER COMPOUNDS OF MURAMYL-PEPTIDE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, IN PARTICULAR IN THE FORM OF LIPOSOMES
FR2420545A1 (en) * 1978-03-20 1979-10-19 Anvar NEW ESTERS OF N-ACETYL-MURAMYL-AMINOACYL-GLUTAMIC ACID OR SUBSTITUTION DERIVATIVES THEREOF WITH ANTI-INFECTIOUS PROPERTIES AND / OR IMMUNOLOGICAL ADJUVANTS
FR2428050A1 (en) * 1978-06-05 1980-01-04 Anvar OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
FR2428051A1 (en) * 1978-06-05 1980-01-04 Anvar NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (en) 1979-02-20 1980-09-19 Anvar NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (en) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogous procedure for the preparation of pharmacologically acting lipophilic a phosphatidylmuramyl peptides.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (en) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (en) 1979-10-12 1981-04-13 Ciba Geigy Ag FOERFARANDE FOER FRAMSTAELLNING AV MYRAMYLPEPTIDER
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
GR78246B (en) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (en) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka Muramyldipeptide active ester derivative
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
WO2006118327A1 (en) * 2005-04-27 2006-11-09 Oxygenix Co Ltd Cationic amino acid type lipid
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (en) 2017-08-21 2020-07-13 Celgene Corp Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopent anoate.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
AR220686A1 (en) 1980-11-28
FI64164B (en) 1983-06-30
ZA767333B (en) 1977-11-30
DK154654C (en) 1989-05-08
CH613709A5 (en) 1979-10-15
SU747430A3 (en) 1980-07-23
FR2361902B1 (en) 1980-11-07
DK552476A (en) 1977-06-11
IE44190B1 (en) 1981-09-09
CS205028B2 (en) 1981-04-30
SG11083G (en) 1983-09-16
SE7613851L (en) 1977-06-11
DD129781A5 (en) 1978-02-08
PL110353B1 (en) 1980-07-31
PT65946B (en) 1978-06-14
FR2361902A1 (en) 1978-03-17
PL194291A1 (en) 1978-10-23
MY8400123A (en) 1984-12-31
AT365607B (en) 1982-02-10
NL7613666A (en) 1977-06-14
DE2655500C2 (en) 1988-12-22
FI763541A (en) 1977-06-11
ATA909276A (en) 1981-06-15
PL110787B1 (en) 1980-07-31
ES454118A1 (en) 1978-03-01
NO144850C (en) 1981-11-25
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
CS205025B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
CS205026B2 (en) 1981-04-30
DE2655500A1 (en) 1977-06-23
AR224091A1 (en) 1981-10-30
DK154654B (en) 1988-12-05
IL51076A (en) 1980-09-16
FI64164C (en) 1983-10-10
IE44190L (en) 1977-06-10
CA1262400A (en) 1989-10-17
BE849214A (en) 1977-06-09
JPS638118B2 (en) 1988-02-19
PL112672B1 (en) 1980-10-31
IL51076A0 (en) 1977-02-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AU508764B2 (en) 1980-04-03
JPS5273820A (en) 1977-06-21
SU660589A3 (en) 1979-04-30
HU177970B (en) 1982-02-28
SE445923B (en) 1986-07-28
AU2042276A (en) 1978-06-15
PT65946A (en) 1977-01-01
SU1060118A3 (en) 1983-12-07
CH614718A5 (en) 1979-12-14
NO144850B (en) 1981-08-17
NO764191L (en) 1977-06-13

Similar Documents

Publication Publication Date Title
ES454118A1 (en) Glucosamine derivatives and a process for their manufacture
PL304419A1 (en) Urease based vaccine against heliobacter infections
MX9301706A (en) VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
ES487046A1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them.
ES442382A1 (en) Red pigment and process
DE3064259D1 (en) Vaccine for preventing persistent feline leukemia viremia in cats and process for preparing it
ES442144A1 (en) 4{40 -Epi-6{40 -hydroxyadriamycin and method of use
ES458197A1 (en) Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
GB1515019A (en) Substituted imidazolidines and pharmaceutical uses thereo
EP0048422A3 (en) Pili of pseudomonas aeruginosa and utilization of same as vaccines against infectionary p.aeruginosa
NO913131L (en) IMMUNOGENIC CONJUGATES OF NON-TOXIC OLIGOSACCHARIDE FROM TABLE TELL PERTUSSIS LIPOOLYSACCHARIDE.
GR33644B (en) METHOD FOR THE PREPARATION OF NEW HALOGEN-PLACED TETRAHYDRO-QINAZOLINE.
SE7703770L (en) METHOD OF MANUFACTURING NEW AMINO SUGAR DERIVATIVES AND USING THEM AS A MEDICINE
ES446637A1 (en) Acellular vaccines
JPS5273826A (en) Preparation of organosilanes
JPS51147869A (en) Turn table equipment driven by linear motor
ES438834A1 (en) Benzhydryloxyalkylamine derivatives and process for the preparation thereof
GB1475481A (en) 1-n-alpha-hydroxy-omega-aminoalkanoyl-6-n-methyl-3,4-dideoxy kanamycin b and the production thereof
JPS51125728A (en) Novel non-medical germicides and their preparation
DK0459176T3 (en) Oligophosphates with antiviral action
FR2287912A1 (en) Sepharose type polysaccharides with amino-acid, pref glycine, gps - useful as non-specific immunity adjuvants for vaccines
JPS51141880A (en) Process for preparing carbostyril derivatives
JPS51150590A (en) A process for preparing water-resistant pullulan
GR25079B (en) METHOD FOR THE PREPARATION OF COMPOSITIONS OF THE CARVAZOLIC SERIES.
IE38289L (en) Bis [azapolycycloalkylalkoxy] fluorenes.